GxP Consulting Announces New Expansion Strategy into US and UK Markets
GxP consulting, provider of compliance services to the pharmaceutical and biopharmaceutical industries, announced expansion plans in the US and UK markets. Led by Mark Stevens, managing director at GxP Consulting, the company has launched a strategy to expand services and support to customers in Europe and America in order to help businesses rise to the challenges currently being faced across the industry.
As part of this expansion, GxP Consulting announces a strategic new facility in Irvine, California, to support increased activity in North America. Secondly, expansion in the UK has led GxP Consulting to move its headquarters into a new larger purpose-built facility in Nottingham. With a dedicated team of 40 consultants in place, GxP Consulting is ideally placed to move forward with its new growth strategy and improved customer support in both regions.
Mark comments: "This is an exciting time for GxP Consulting. We recently marked our ten year anniversary, which is a significant milestone for any business and the next step for us is to push forward with our expansion strategy across both the USA and UK. In the last 12 months, our plans have seen us move to new headquarters in Nottingham, launch a brand new client-centric website and extend our range of services. 2009 is a crucial year for the company as we look to build on our success over the last 12 months, extend our customer support throughout Europe and North America and continue to grow our portfolio of services."
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Fantastic muscle proteins and where to find them - “This is going to be unexpected even for myosin researchers”

Cancer Treatment with Built-in Light - Deep photodynamic therapy: photosensitizer irradiates itself
Silence Therapeutics Forms Scientific Advisory Board
InteRNA Technologies and Dana-Farber Cancer Institute to collaborate on the role of microRNAs in cancer pathways
Bayer Animal Health and Paraco agree on access to lead molecules

Wiggly proteins guard the genome - Dynamic network in the pores of the nuclear envelope blocks dangerous invaders

Defective immune cells in the brain cause Alzheimer’s disease - Scientists are studying the role of immune cell activation in Alzheimer's disease

Sepsis in Children: Improved Diagnosis Thanks to New Global Criteria - Researchers applied machine-learning methods to extrapolate from the data analysis evidence-based criteria for diagnosing
